Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances. The following outlines must be followed.
generic (Brand) Route [Packaging: Mfg ⇒ Dispense]
NIOSH Group
OXcarbazepine (Oxtellar XR, Trileptal) PO [UD ⇒ UD]
Non - Antineoplastic
Pharmacy: Receiving / Storage / Preparation
Exposure Risk: minimal
• Handling/preparation PPE Requirements: n/a
• Receiving from Distributor: Standard
• Pharmacy Storage Area: Carousel
• Packaging/Reconstitution Location: n/a
• Compounding (Non-Sterile/Sterile) Location: n/a
• Omnicell Load: Yes
Transport
• Transport (dose is placed inside a plastic sealable bag): Standard
Nursing: Storage / Admin.
Exposure Risk: low
• Handling/administration PPE Requirements: PO- Single CX gloves , tube- double CX gloves and gown , wash hands after handling
• Storage of Finished dose in Nursing Area/Procedural Area: Patient Med Drawer, Omnicell
• Signage on Patient Door Required: No
• Manipulation of Dosage Form: Standard
• Special Manipulation for Administration: n/a
Disposal / Spills
• Disposal of Drug Waste: Full- blue bin , trace/packaging- trash
• Disposol of Used PPE: trash bin (inside plastic bag)
• Spill management: n/a
NIOSH Supplemental Information: Tumors observed in lab studies at 1/10 MRHD
Reason for exemption of USP<800> Containment Requirements: Purchased in final dosage form; packaged as unit dose. Does not require additional manipulation for dispensing.
Last updated: Dec. 23, 2021
Hazard.Drug Handling(USP 800) USP<800> Hazardous Drug / Assessment of Risk
Look-Alike/Sound-Alike OXcarbazepine confused with oxaprozin, carBAMazepine
The following outlines must be followed.
Receiving /
Storage /
Preparation
minimal
Storage /
Admin.
low
Spills